How we can continue to innovate in the care of rare diseases
The UK has a compelling offer in cutting-edge science, but more must be done to realise its potential.
ByNew Times,
New Thinking.
Kylie Bromley is Biogen's Managing Director for the United Kingdom & Ireland.
The UK has a compelling offer in cutting-edge science, but more must be done to realise its potential.
By Kylie BromleyWhy we must work together to transform care.
By Kylie Bromley